OnDemand WTP Pricing Research

Tag: rebates

Lilly, other insulin makers must face price-gouging lawsuit, judge rules | Indianapolis Business Journal

Lilly, other insulin makers must face price-gouging lawsuit, judge rules | Indianapolis Business Journal

Indianapolis-based Eli Lilly and Co. and two other insulin makers must face claims they gouged diabetes patients through deceptive price lists for their life-saving drugs. U.S. District Judge Brian Martinotti in New Jersey on Friday allowed a proposed class-action lawsuit filed by 67 diabetics against Lilly, Novo Nordisk A/S and the U.S. unit of French […]

Why Does A Once-Free Drug Now Cost $375,000 A Year? | Care2 Causes

Why Does A Once-Free Drug Now Cost $375,000 A Year? | Care2 Causes

Senator Bernie Sanders is taking on a large pharmaceuticals company and demanding to know why a life-saving drug for a rare condition has seen its price increase by hundreds of thousands of dollars. Sanders, who has made the problem of drug pricing a major focus of his time in the Senate, released a letter dated February 4 and […]

How Team Trump is bringing drug prices down | NY Post

How Team Trump is bringing drug prices down | NY Post

When you go out and make a major purchase for yourself or your family, do you ever do it without first knowing what it’s going to cost you? Of course not. Yet that is what our health care system asks of millions of Americans every day, when they make health care decisions without knowing what […]

The illusion and cost of drug rebates | Washington Times

The illusion and cost of drug rebates | Washington Times

President Trump and every declared candidate for the presidency want to lower drug costs. And, surprise, it’s the president who has made a bold move toward a workable free market solution. His new proposal cracks down on the price-gouging practices of middlemen in the drug supply chain — Prescription Benefit Managers (PBMs), the mega-corporations that […]

Price of insulin more than doubled over five years | CBS News

Price of insulin more than doubled over five years | CBS News

The cost of insulin for Type 1 diabetics has almost doubled over a five-year period, highlighting the financial strain that many diabetics face when paying for treatment. Type 1 diabetics spent about $5,700 a year on the life-saving drug in 2016, up from about $2,900 in 2012, according to a new analysis from the nonprofit […]

Better health care price transparency coming soon | Wyoming Business Report

Better health care price transparency coming soon | Wyoming Business Report

SWEETWATER COUNTY — In April the Centers for Medicare and Medicaid Services proposed a new rule requiring hospitals to publish a list of standard charges on their websites. The rule will go into effect on Jan. 1, 2019. The goal of the rule is to “empower patients through better access to hospital price information, improve […]

Health IT Adoption of Surescripts Price Transparency Tool Surges | EHR Intelligence

Health IT Adoption of Surescripts Price Transparency Tool Surges | EHR Intelligence

November 16, 2018 – Surescripts is experiencing a surge in new users as health IT adoption of its Real-Time Prescription Benefit tool increases fortyfold in a year. Prescribers have so far used the tool 30 million times to view patient-specific price and therapeutic alternative information since the EHR-integrated tool’s launch in 2017. EHR vendors comprising 77 […]

Answering Your Questions about the IPI Drug Pricing Model | HHS

Answering Your Questions about the IPI Drug Pricing Model | HHS

How will this model affect patient access? Could this change my Medicare benefits? The IPI model does not include any restrictions on patient access or choice of drugs. This stands in marked contrast to proposals that would impose formularies in order to negotiate down drug prices. Given the size of the U.S. drug market and […]

Lack of price transparency, consolidation, reimbursements & more: 4 key issues facing ASCs | Becker’s ASC Review

Lack of price transparency, consolidation, reimbursements & more: 4 key issues facing ASCs | Becker’s ASC Review

Almost every other industry has price transparency, and it is time for healthcare to catch up, said Stephen Blake, JD, CEO of Arlington, Texas-based Central Park ENT & Surgery Center. “We need to bend the cost curve. Price transparency should be our culture. Every other industry has the capability. We shouldn’t be the only industry […]

Lack of price transparency, consolidation, reimbursements & more: 4 key issues facing ASCs | BEcker’s ASC

Lack of price transparency, consolidation, reimbursements & more: 4 key issues facing ASCs | BEcker’s ASC

Almost every other industry has price transparency, and it is time for healthcare to catch up, said Stephen Blake, JD, CEO of Arlington, Texas-based Central Park ENT & Surgery Center. “We need to bend the cost curve. Price transparency should be our culture. Every other industry has the capability. We shouldn’t be the only industry […]